Skip to main content
Livermore
Livermore
ZHEN

Stephens Inc

SEC CIK
0000757657
Latest filing
Jul 29, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Stephens Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
2,900
Value
$1.44M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Stephens Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,900$1.44M<0.1%−51−1.7%ReducedHolders
Q1 20262,951$1.32M<0.1%−143−4.6%ReducedHolders
Q4 20253,094$1.40M<0.1%−470−13.2%ReducedHolders
Q3 20253,564$1.40M<0.1%+172+5.1%AddedHolders
Q2 20253,392$1.51M<0.1%+77+2.3%AddedHolders
Q1 20253,315$1.61M<0.1%−138−4.0%ReducedHolders
Q4 20243,453$1.39M<0.1%−95−2.7%ReducedHolders
Q3 20243,548$1.65M<0.1%−160−4.3%ReducedHolders
Q2 20243,708$1.74M<0.1%−360−8.8%ReducedHolders
Q1 20244,068$1.70M<0.1%+43+1.1%AddedHolders
Q4 20234,025$1.64M<0.1%−320−7.4%ReducedHolders
Q3 20234,345$1.51M<0.1%−59−1.3%ReducedHolders
Q2 20234,404$1.55M<0.1%−300−6.4%ReducedHolders
Q1 20234,704$1.48M<0.1%+274+6.2%AddedHolders
Q4 20224,430$1.28M<0.1%−274−5.8%ReducedHolders
Q3 20224,704$1.36M<0.1%−1,755−27.2%ReducedHolders
Q2 20226,459$1.82M<0.1%−1,000−13.4%ReducedHolders
Q1 20227,459$1.95M<0.1%−4,044−35.2%ReducedHolders
Q4 202111,503$2.53M<0.1%−2,496−17.8%ReducedHolders
Q3 202113,999$2.54M<0.1%−3,588−20.4%ReducedHolders
Q2 202117,587$3.55M0.1%−74−0.4%ReducedHolders
Q1 202117,661$3.79M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.